September 10, 2026 VivoSim Labs, Inc. (NASDAQ: VIVS) is targeting one of pharmaceutical development's most expensive challenges: identifying drug toxicity before a candidate reaches human clinical trials. Using its NAMkind™ 3D human liver and intestinal models combined with AI-powered predictive toxicology, VivoSim is developing tools designed to help pharmaceutical companies determine which drug candidates should advance, be modified or be discontinued earlier .
Gainers Megan Holdings (NASDAQ:MGN) stock increased by 320.2% to $0.42 during Wednesday's regular session. SUNation Energy (NASDAQ:SUNE) stock moved upwards by 51.05% to $3.58. The market value of their
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN) and reminds investors of the September 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Megan (MGN) To Contact Him Directly To Discuss Their Options
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s September 26, 2025 initial public offering; and/or (b) securities between September 26, 2025 and March 25, 2026, inclusive (the “Class Period”).
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Megan (MGN) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Megan (MGN) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s September 26, 2025 initial public offering; and/or (b) securities between September 26, 2025 and March 25, 2026, inclusive (the “Class Period”).
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Megan (MGN) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN) of the September 8, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Megan (MGN) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited (“Megan” or the “Company”) (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
